ArticleAnnals of hematology2022
The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
Denis Soulières et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it